HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mathew, T. C. Articles by Pezzella, A. T. Search for Related Content PubMed PubMed Citation Articles by Mathew, T. C. Articles by Pezzella, A. T.

Ann Thorac Surg 1997;64:1059-1062
© 1997 The Society of Thoracic Surgeons

---

Original Article: Cardiovascular

Coronary Artery Bypass Grafting in Immune Thrombocytopenic Purpura

Department of Medicine and Divisions of Cardiology, Hematology/Oncology, and Cardiothoracic Surgery, Saint Vincent Hospital and University of Massachusetts Medical School, Worcester, Massachusetts

Accepted for publication April 11, 1997.

Background. Reports of patients with idiopathic thrombocytopenic purpura undergoing cardiac operations are scarce and no recommendations exist regarding their management. We report 3 patients with idiopathic thrombocytopenic purpura and severe coronary artery disease who underwent uncomplicated coronary bypass grafting.

Methods. The case history of each patient with idiopathic thrombocytopenic purpura who underwent coronary artery bypass grafting and the literature were reviewed.

Results. All 3 patients underwent uncomplicated coronary artery bypass grafting after preoperative treatment with intravenous immunoglobulin and intraoperative platelet transfusions if needed. Prophylactic splenectomy was not performed. There was no increased incidence of bleeding complications.

Conclusions. Coronary artery bypass grafting can be safely performed in patients with idiopathic thrombocytopenic purpura using conventional conduits after pretreating with immunoglobulin G and avoiding splenectomy.

This article has been cited by other articles:

				The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]

				Y. Inoue, R. C. H. Lim, and P. Nand Coronary artery bypass grafting in an immune thrombocytopenic purpura patient using off-pump techniques Ann. Thorac. Surg., May 1, 2004; 77(5): 1819 - 1821. [Abstract] [Full Text] [PDF]

				K. Nakamura, T. Onitsuka, M. Yano, H. Nagahama, E. Nakamura, and Y. Matsuzaki Nafamostat mesilate treatment during open heart operation in immune thrombocytopenic purpura Ann. Thorac. Surg., December 1, 2000; 70(6): 2161 - 2163. [Abstract] [Full Text] [PDF]

				S. Christiansen, J. Rotker, N. Roeder, U. R. Jahn, J. Stypmann, H. H. Scheld, and C. Schmid Are patients with Werlhof's disease at increased risk for bleeding complications when undergoing cardiac surgery? Eur. J. Cardiothorac. Surg., September 1, 2000; 18(3): 353 - 356. [Abstract] [Full Text] [PDF]

				T. Koyanagi, S. Kyo, E. Hirooka, I. Koyama, and R. Omoto Redo without transfusion in a patient with idiopathic thrombocytopenic purpura Ann. Thorac. Surg., April 1, 2000; 69(4): 1261 - 1263. [Abstract] [Full Text] [PDF]

				S. Christiansen, C. Schmid, K. Redmann, U. R. Jahn, J. Stypmann, H. H. Scheld, and D. Hammel Preoperative immunoglobulin treatment in patients with Werlhof's disease undergoing cardiac operation Ann. Thorac. Surg., January 1, 2000; 69(1): 61 - 64. [Abstract] [Full Text] [PDF]